Pricing Log in Create free account
Friday 6 November 2026 Export HQY’s income statement to Excel — free account

HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.

Revenue
+7.64%
EPS
+14.5%
Free cash flow
−3.44%
Total debt
−7.53%

Quarter to July 2026, against a year earlier

103.04 0.42 −0.41%
Market cap
$8.6B
P/E
36.9×
Fwd P/E
34.8×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

HealthEquity, Inc. (HQY) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 5, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Sep 24, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure
10-Q Jul 31, 2026 P1I2: 16 added · 1 removed · 26 modified
P2I1A: no material changes, the filing says
8-K Aug 27, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 25, 2026 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Apr 30, 2026
8-K May 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 5, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Apr 6, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Mar 26, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Jan 31, 2026 1: 5 added · 5 removed · 47 modified
1A: 7 added · 5 removed · 56 modified
7: 7 added · 12 removed · 68 modified
8-K Mar 17, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 17, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Oct 31, 2025
8-K Dec 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jul 31, 2025
8-K Sep 2, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Apr 30, 2025
8-K Jun 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Jan 31, 2025
8-K Mar 18, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 18, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Oct 31, 2024
8-K Dec 9, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jul 31, 2024
8-K Sep 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 19, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 21, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 5, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.